α-Glucosidase inhibitory effect of resveratrol and piceatannol

Journal of Nutritional Biochemistry

Volumn 47, Issue , 2017, Pages 86-93

  Zhang, Albert J ^a,c   Rimando, Agnes M ^b   Mizuno, Cassia S ^b,d   Mathews, Suresh T ^a,e  

^a AUBURN UNIVERSITY   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d UNIVERSITY OF NEW ENGLAND   (United States)

^e SAMFORD UNIVERSITY   (United States)

Author keywords

3 Hydroxypterostilbene; Diabetes; Obesity; Piceatannol; Resveratrol; Stilbenes; Glucosidase

Indexed keywords

3' HYDROXYPTEROSTILBENE; ACARBOSE; ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; DESOXYRHAPONTIGENIN; MALTOSE; PICEATANNOL; PINOSTILBENE; RESVERATROL; STARCH; STILBENE DERIVATIVE; SUCROSE; UNCLASSIFIED DRUG; 3'-HYDROXYPTEROSTILBENE; 3,3',4,5'-TETRAHYDROXYSTILBENE; GASTROINTESTINAL AGENT; GLYCOSIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CARBOHYDRATE ABSORPTION; CONTROLLED STUDY; DIABETES MELLITUS; DIET INDUCED OBESITY; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IC50; IN VITRO STUDY; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; ANALYSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CARBOHYDRATE DIET; CHEMISTRY; COMPARATIVE STUDY; DIET THERAPY; DRUG EFFECT; INTESTINE ABSORPTION; KINETICS; LIPID DIET; METABOLISM; OBESITY; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; RANDOMIZATION; RAT; SUGAR INTAKE;

ACARBOSE; ALPHA-GLUCOSIDASES; ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; DIETARY CARBOHYDRATES; DIETARY SUCROSE; GASTROINTESTINAL AGENTS; GLYCOSIDE HYDROLASE INHIBITORS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INTESTINAL ABSORPTION; KINETICS; MICE, INBRED C57BL; OBESITY; POSTPRANDIAL PERIOD; RANDOM ALLOCATION; RATS; STARCH; STILBENES;

EID: 85019753255     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2017.05.008     Document Type: Article

References (52)

1. Centers for Disease Control and Prevention, Diabetes. Working to reverse the US epidemic. http://www.cdc.gov/chronicdisease/resources/publications/aag/diabetes.htm [accessed October 28, 2016].
2. World Health Organization, Diabetes fact sheet. June 2016. http://www.who.int/mediacentre/factsheets/fs312/en/ [accessed October 28, 2016].
3. Scheen, A.J., Is there a role for α-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?. Drugs 63 (2003), 933–951.
4. Bell, D.S., Type 2 diabetes mellitus: what is the optimal treatment regimen?. Am J Med(116 Suppl), 2004, 23S–29S.
5. Van de Laar, F.A., Lucassen, P.L., Akkermans, R.P., Van de Lisdonk, E.H., Rutten, G.E., Van Weel, C., α-Glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev, 18, 2005, CD003639.
6. Frombaum, M., Le Clanche, S., Bonnefont-Rousselot, D., Borderie, D., Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and NO bioavailability: potential benefits to cardiovascular diseases. Biochimie 94 (2012), 269–276.
7. Lee, H.H., Park, S.A., Almazari, I., Kim, E.H., Na, H.K., Surh, Y.J., Piceatannol induces heme oxygenase-1 expression in human mammary epithelial cells through activation of ARE-driven Nrf2 signaling. Arch Biochem Biophys 501 (2010), 142–150.
8. Mikstacka, R., Rimando, A.M., Ignatowicz, E., Antioxidant effect of trans-resveratrol, pterostilbene, quercetin and their combinations in human erythrocytes in vitro. Plant Foods Hum Nutr 65 (2010), 57–63.
9. Rimando, A.M., Cuendet, M., Desmarchelier, C., Mehta, R.G., Pezzuto, J.M., Duke, S.O., Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J Agric Food Chem 50 (2002), 3453–3457.
10. Hung, L.M., Su, M.J., Chen, J.K., Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms. Free Radic Biol Med 36 (2004), 774–781.
11. Wang, Z., Zou, J., Cao, K., Hsieh, T.C., Huang, Y., Wu, J.M., Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int J Mol Med 16 (2005), 533–540.
12. Kraft, T.E., Parisotto, D., Schempp, C., Efferth, T., Fighting cancer with red wine? Molecular mechanisms of resveratrol. Crit Rev Food Sci Nutr 49 (2009), 782–799.
13. Kang, O.H., Jang, H.J., Chae, H.S., Oh, Y.C., Choi, J.G., Lee, Y.S., et al. Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-κB and MAPK. Pharmacol Res 59 (2009), 330–337.
14. Rizvi, S.I., Pandey, K.B., Activation of the erythrocyte plasma membrane redox system by resveratrol: a possible mechanism for antioxidant properties. Pharmacol Rep 62 (2012), 726–732.
15. Riviere, C., Richard, T., Quentin, L., Krisa, S., Merillon, J.M., Monti, J.P., Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro. Bioorg Med Chem 15 (2007), 1160–1167.
16. Albani, D., Polito, L., Signorini, A., Forloni, G., Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 36 (2010), 370–376.
17. Kim, H.J., Lee, W., Lee, H.J., Protective effects of piceatannol against beta-amyloid-induced neuronal cell death. Ann N Y Acad Sci 1095 (2007), 473–482.
18. Kuo, P.L., Hsu, Y.L., The grape and wine constituent piceatannol inhibits proliferation of human bladder cancer cells via blocking cell cycle progression and inducing Fas/membrane bound Fas ligand-mediated apoptotic pathway. Mol Nutr Food Res 52 (2008), 408–418.
19. Son, P.S., Park, S.A., Na, H.K., Jue, D.M., Kim, S., Surh, Y.J., Piceatannol, a catechol-type polyphenol, inhibits phorbol ester-induced NF-κB activation and cyclooxygenase-2 expression in human breast epithelial cells: cysteine 179 of IKKβ as a potential target. Carcinogenesis 31 (2010), 1442–1449.
20. Cichocki, M., Paluszczak, J., Szaefer, H., Piechowiak, A., Rimando, A.M., Baer-Dubowska, W., Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFκB, AP-1, COX-2, and iNOS in mouse epidermis. Mol Nutr Food Res 52:Suppl. 1 (2008), S62–S70.
21. Choi, S.Z., Lee, S.O., Jang, K.U., Chung, S.H., Park, S.H., Kang, H.C., et al. Antidiabetic stilbene and anthraquinone derivatives from Rheum undulatum. Arch Pharm Res 28 (2005), 1027–1030.
22. Kerem, Z., Bilkis, I., Flaishman, M.A., Sivan, L., Antioxidant activity and inhibition of alpha-glucosidase by trans-resveratrol, piceid, and a novel trans-stilbene from the roots of Israeli Rumex bucephalophorus L. J Agric Food Chem 54 (2006), 1243–1247.
23. Li, J.M., Che, C.T., Lau, C.B., Leung, P.S., Cheng, C.H., Desoxyrhaponticin (3,5-dihydroxy-4′-methoxystilbene 3-O-beta-D-glucoside) inhibits glucose uptake in the intestine and kidney: in vitro and in vivo studies. J Pharmacol Exp Ther 320 (2007), 38–46.
24. Manickam, M., Ramanathan, M., Jahromi, M.A., Chansouria, J.P., Ray, A.B., Antihyperglycemic activity of phenolics from Pterocarpus marsupium. J Nat Prod 60 (1997), 609–610.
25. Kubo, I., Murai, Y., Soediro, I., Soetarno, S., Sastrodihardjo, S., Efficient isolation of glycosidase inhibitory stilbene glycosides from Rheum palmatum. J Nat Prod 54 (1991), 1115–1118.
26. Lam, S.H., Chen, J.M., Kang, C.J., Chen, C.H., Lee, S.S., α-Glucosidase inhibitors from the seeds of Syagrus romanzoffiana. Phytochemistry 69 (2008), 1173–1178.
27. Wan, X., Wang, X.B., Yang, M.H., Wang, J.S., Kong, L.Y., Dimerization of piceatannol by Momordica charantia peroxidase and α-glucosidase inhibitory activity of the biotransformation products. Bioorg Med Chem 19 (2011), 5085–5092.
28. Mizuno, C.S., Ma, G., Khan, S., Patny, A., Avery, M.A., Rimando, A.M., Design, synthesis, biological evaluation and docking studies of pterostilbene analogs inside PPARα. Bioorg Med Chem 16 (2008), 3800–3808.
29. Mizuno, C.S., Schrader, K.K., Rimando, A.M., Algicidal activity of stilbene analogues. J Agric Food Chem 56 (2008), 9140–9145.
30. Rimando, A.M., Nagmani, R., Feller, D.R., Yokoyama, W., Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. J Agric Food Chem 53 (2005), 3403–3407.
31. Tolomeo, M., Grimaudo, S., Di Cristina, A., Roberti, M., Pizzirani, D., Meli, M., et al. Pterostilbene and 3′-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. Int J Biochem Cell Biol 37 (2005), 1709–1726.
32. Watanabe, J., Kawabata, J., Kurihara, H., Niki, R., Isolation and identification of alpha-glucosidase inhibitors from tochu-cha (Eucommia ulmoides). Biosci Biotechnol Biochem 61 (1997), 177–178.
33. Kim, Y.-M., Kim, M.-J., Zhang, J.A., Joo, H.-J., Hwang, J.-Y., Kim, J.-I., et al. Isolation of an active compound with alpha-glucosidase inhibitory activity from Amomum Xanthioides Wallich. FASEB J, 21, 2007, 845.4.
34. Adachi, T., Mori, C., Sakurai, K., Shihara, N., Tsuda, K., Yasuda, K., Morphological changes and increased sucrase and isomaltase activity in small intestines of insulin-deficient and type 2 diabetic rats. Endocr J 50 (2003), 271–279.
35. Shinde, J., Taldone, T., Barletta, M., Kunaparaju, N., Hu, B., Kumar, S., et al. α-Glucosidase inhibitory activity of Syzygium cumini (Linn.) Skeels seed kernel in vitro and in Goto-Kakizaki (GK) rats. Carbohydr Res 343 (2008), 1278–1281.
36. Weng, Y.L., Liao, H.F., Li, A.F., Chang, J.C., Chiou, R.Y., Oral administration of resveratrol in suppression of pulmonary metastasis of BALB/c mice challenged with CT26 colorectal adenocarcinoma cells. Mol Nutr Food Res 54 (2010), 259–267.
37. Borgohain, M.P., Lahkar, M., Ahmed, S., Chowdhury, L., Kumar, S., Pant, R., et al. Small molecule inhibiting nuclear factor-kB ameliorates oxidative stress and suppresses renal inflammation in early stage of alloxan-induced diabetic nephropathy in rat. Basic Clin Pharmacol Toxicol, 2016, 10.1111/bcpt.12718.
38. Oki, T., Matsui, T., Osajima, Y., Inhibitory effect of α-glucosidase inhibitors varies according to its origin. J Agric Food Chem 47 (1999), 550–553.
39. Babu, K.S., Tiwari, A.K., Srinivas, P.V., Ali, A.Z., China Raju, B., Rao, J.M., Yeast and mammalian α-glucosidase inhibitory constituents from Himalayan rhubarb Rheum emodi Wall.Ex Meisson. Bioorg Med Chem Lett 14 (2004), 3841–3845.
40. Shai, L.J., Magano, S.R., Lebelo, S.L., Mogale, A.M., Inhibitory effects of five medicinal plants on rat α-glucosidase: comparison with their effects on yeast α-glucosidase. J Med Plant Res 5 (2011), 2863–2867.
41. Lee, D.S., Lee, S.H., Genistein, a soy isoflavone, is a potent α-glucosidase inhibitor. FEBS Lett 501 (2001), 84–86.
42. Chi, T.C., Chen, W.P., Chi, T.L., Kuo, T.F., Lee, S.S., Cheng, J.T., et al. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. Life Sci 80 (2011), 1713–1720.
43. Szkudelski, T., The insulin-suppressive effect of resveratrol — an in vitro and in vivo phenomenon. Life Sci 82 (2008), 430–435.
44. Mader, I., Wabitsch, M., Debatin, K.M., Fischer-Posovszky, P., Fulda, S., Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis. FASEB J 24 (2012), 1997–2009.
45. Palsamy, P., Sivakumar, S., Subramanian, S., Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats. Chem Biol Interact 186 (2012), 200–210.
46. Barger, J.L., Kayo, T., Vann, J.M., Arias, E.B., Wang, J., Hacker, T.A., et al. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One, 3(6), 2008, e2264 [1-10].
47. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127 (2006), 1109–1122.
48. Kwon, J.Y., Seo, S.G., Heo, Y.S., Yue, S., Cheng, J.X., Lee, K.W., et al. Piceatannol, a natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in the early phase of differentiation. J Biol Chem 287 (2012), 11566–11578.
49. Kobayashi, K., Ishihara, T., Khono, E., Miyase, T., Yoshizaki, F., Constituents of stem bark of Callistemon rigidus showing inhibitory effects on mouse α-amylase activity. Biol Pharm Bull 29 (2006), 1275–1277.
50. Fauconneau, B., Waffo-Teguo, P., Huguet, F., Barrier, L., Decendit, A., Merillon, J.M., Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 61 (1997), 2103–2110.
51. Larrosa, M., Tomas-Barberan, F., Espin, J.C., Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells. J Agric Food Chem 1 (2003), 576–4584.
52. Matsuoka, A., Takeshita, K., Furuta, A., Ozaki, M., Fukuhara, K., Miyata, N., The 4′-hydroxy group is responsible for the in vitro cytogenetic activity of resveratrol. Mutat Res 521 (2002), 29–35.